Guangzhou Baiyunshan Pharmaceutical Holdings manufactures and sells Chinese patent medicine.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 23, 2022 | Post-IPO Equity | $1.43M | 1 |
Source Capital
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Source Capital
|
Yes | Post-IPO Equity |